1, the training of pharmaceutical production enterprises should be mainly carried out in accordance with the GMP (good manufacturing practice) certification requirements issued by the US Food and Drug Administration: 1, off-job training, basic knowledge of GMP certification; 2. Training of pharmaceutical production personnel (including QA, director of pharmaceutical quality): pharmaceutical production process regulations, post operation regulations, production management regulations, equipment operation and maintenance cleaning regulations, etc. 3. Drug quality inspection (QC) and quality supervision personnel (QA): product standards, product inspection standards and inspection operation procedures; 4. Equipment maintenance personnel: equipment maintenance procedures, equipment cleaning procedures, etc.

Pharmaceutical enterprises refer to enterprises in the pharmaceutical industry, which can be divided into pharmaceutical production enterprises and pharmaceutical trading enterprises. According to the definition in Article 102 of the Drug Administration Law of People's Republic of China (PRC) (hereinafter referred to as the Drug Administration Law), the so-called drug production enterprise refers to a franchise enterprise or a part-time enterprise that produces drugs. The so-called pharmaceutical trading enterprises refer to franchised enterprises or part-time enterprises dealing in pharmaceuticals.

2. After a long period of sustained and high-speed growth, the pharmaceutical industry in China has gradually exposed various contradictions that affect the development of the industry, and the pharmaceutical industry in China has entered a critical development period in which crisis and turnaround coexist. How will China's pharmaceutical industry develop in the future, how will the market competition pattern evolve, how will pharmaceutical enterprises cope with the new round of market competition and reshuffle, and which pharmaceutical enterprises can obtain the right to exist in the future? We must think rationally from the height of industrial development, make careful preparations and respond positively.

Enlightenment from Western Industrial History

The Morgan era of North American industry (1880~ 1920) is an important period in the history of western industrial development. The market competition and industrial structure adjustment in this period have important reference significance for the development of our pharmaceutical industry today. At that time, the pattern of industrial competition was low-level repeated construction, numerous manufacturers, vicious competition, price war, chaotic market order, and manufacturers in the industry were struggling to survive.

The American pharmaceutical industry has also experienced this process of industrial restructuring. 19 At the end of the 20th century, the number of pharmaceutical enterprises in the United States once reached more than 3,000. In the following 20~30 years, nearly half of pharmaceutical enterprises withdrew from the market. After a century of market competition and mergers and acquisitions, the structure of American pharmaceutical industry has been constantly adjusted, optimized and upgraded, and the market concentration has been greatly improved. Today, there are only a few hundred pharmaceutical companies in the United States. They are either multinational pharmaceutical enterprise groups with strong competitiveness or high-tech biopharmaceutical enterprises with specialized and characteristic development.

3. In order to ensure safe production, protect the company's property from loss and personnel from injury, and ensure safe operation and hidden danger investigation. Pharmaceutical companies (factories) must send people on duty 24 hours a day.